6533b822fe1ef96bd127d62b

RESEARCH PRODUCT

Physiological pharmacokinetic model for ceftazidime disposition in the rat and its application to prediction of plasma concentrations in humans

Luis GraneroJesús Chesa-jiménezF Torres-molinaJ E Peris-riberaMercedes AlmelaVíctor MonserratMaría-josé Gimeno

subject

Volume of distributionImpaired renal functionPharmacokineticsPlasma concentrationmedicinePharmaceutical ScienceDistribution (pharmacology)CeftazidimeDispositionPharmacologyBiologyAntibacterial agentmedicine.drug

description

Abstract A physiological pharmacokinetic model for the disposition of ceftazidime in the rat was developed. The model is composed of 10 compartments which represent most of the organs and tissues of the body. Ceftazidime concentration-time profiles in the organs and tissues represented in the model were simulated and compared with the observed concentration-time data after i.v. administration of 5 and 20 mg of antibiotic. The model gave an acceptable description of the observed data. The steady-state volume of distribution and total clearance of ceftazidime in healthy humans predicted from data obtained in the rat (0.21 l/kg and 113 ml/min, respectively) were similar to the values reported for these parameters by several authors. The model was scaled to humans by using the tissue volumes and plasma flow rates corresponding to a standard man, the tissue-to-plasma partition coefficients determined in rats, and the total plasma clearance of ceftazidime observed in humans. Good predictions of plasma concentrations of ceftazidime in normal subjects and patients with various degrees of impaired renal function were obtained.

https://doi.org/10.1016/0928-0987(93)90012-y